Multiply Labs

Manufacturing individualized drugs is slow and expensive because current processes rely heavily on manual labor.

The company provides cloud-controlled modular robotic systems deployed in pharma facilities as robotics-as-a-service to scale production of individualized drugs.

Pharmaceutical manufacturers and drug developers producing next-generation individualized therapies.